Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inlyta in advanced melanoma
NCT01533948Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jan 2012
- Primary completion
- Jul 2015
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in melanoma, sponsored by Roswell Park Comprehensive Cancer Center. Started Jan 2012; status: terminated.
02
Drugs
axitinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01533948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01533948.